Junko Nagai

518 total citations
35 papers, 403 citations indexed

About

Junko Nagai is a scholar working on Pharmacology, Organic Chemistry and Toxicology. According to data from OpenAlex, Junko Nagai has authored 35 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 13 papers in Organic Chemistry and 5 papers in Toxicology. Recurrent topics in Junko Nagai's work include Synthesis of Organic Compounds (11 papers), Multicomponent Synthesis of Heterocycles (6 papers) and Synthesis and biological activity (4 papers). Junko Nagai is often cited by papers focused on Synthesis of Organic Compounds (11 papers), Multicomponent Synthesis of Heterocycles (6 papers) and Synthesis and biological activity (4 papers). Junko Nagai collaborates with scholars based in Japan, China and Germany. Junko Nagai's co-authors include Yoshihiro Uesawa, Koichi Takao, Yoshiaki Sugita, Hiroshi Sakagami, Tomoyasu Ishikawa, Yuji Iizawa, Kenji Okonogi, Shohei Hashiguchi, Masafumi Nαkαo and Akio Miyake and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Junko Nagai

31 papers receiving 389 citations

Peers

Junko Nagai
Comparison fields: 5 of 88
  • Pharmacology 154
  • Organic Chemistry 108
  • Molecular Biology 92
  • Infectious Diseases 56
  • Surgery 36
Shalki Choudhary India
Haifeng Cui China
Sara Consalvi Italy
Seiko Hattori Japan
Hanna Kruszewska Poland
Karanvir Singh India
Tetsuya Saita Japan
Atsushi Hirata Japan
Munichandra Babu Tirumalasetty India
Mohd Yaseen Malik India
Shalki Choudhary India View profile →
Citations per field, relative to Junko Nagai
Junko Nagai · 1×
Citations per year, relative to Junko Nagai
Junko Nagai · 1×

Countries citing papers authored by Junko Nagai

Since Specialization
Citations

This map shows the geographic impact of Junko Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Nagai more than expected).

Fields of papers citing papers by Junko Nagai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Nagai. The network helps show where Junko Nagai may publish in the future.

Co-authorship network of co-authors of Junko Nagai

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Nagai. A scholar is included among the top collaborators of Junko Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Nagai. Junko Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Tumor-specific cytotoxicity of pyrazole-based chalcone derivatives in human oral squamous cell carcinoma cell lines TURKISH JOURNAL OF BIOLOGY Halise İnci Gül, Hiroshi Sakagami et al. 0
2 Synthesis and biological evaluation of 3-styrylchromone derivatives as selective monoamine oxidase B inhibitors Bioorganic & Medicinal Chemistry Koichi Takao, Junko Nagai et al. 15
3 Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database PLoS ONE Junko Nagai, Yoichi Ishikawa 14
4 Syntheses and Glycosidase Inhibitory Activities, and in Silico Docking Studies of Pericosine E Analogs Methoxy-Substituted at C6 Marine Drugs Yoshihide Usami, Megumi Higuchi et al. 5
5 Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma SHILAP Revista de lepidopterología Yoshiaki Sugita, Koichi Takao et al. 15
6 Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell CarcinomaIn Vitro Anticancer Research Hiroshi Sakagami, Masashi Hashimoto et al. 6
7 QSAR Prediction Model to Search for Compounds with Selective Cytotoxicity Against Oral Cell Cancer SHILAP Revista de lepidopterología Junko Nagai, Hiroshi Sakagami et al. 9
8 Quantitative Structure–Cytotoxicity Relationship of Azulene Amide Derivatives Anticancer Research Masashi Hashimoto, Hidetsugu Wakabayashi et al. 9
9 Recent Progress of Basic Studies of Natural Products and Their Dental Application SHILAP Revista de lepidopterología Hiroshi Sakagami, Tomonori Hoshino et al. 21
10 Quantitative Structure–Cytotoxicity Relationship of Pyrano[4,3-b]chromones Anticancer Research Junko Nagai, Kenjiro Bandow et al. 15
11 Evaluation Criteria for Clinical Usefulness of Generic Transdermal Adhesive Agents Takuro Okada, Masahito Nakazaki et al. 0
12 Characterization of the Adverse Effects Induced by Acetaminophen and Nonsteroidal Anti-Inflammatory Drugs Based on the Analysis of the Japanese Adverse Drug Event Report Database Clinical Journal of Pain Junko Nagai, Yoshihiro Uesawa et al. 21
13 Cranial Magnetic Resonance Imaging and Angiography Findings in a Patient With Hyperglycemic Hemichorea-Hemiballism The Journal of Clinical Endocrinology & Metabolism Junko Nagai, Tsutomu Yamada et al. 8
14 Effects of Information Provided by Pharmacists on Pharmacotherapy Masahito Nakazaki, Masanori Suzuki et al. 1
15 Assessment of Efficacy and Safety of Branded and Generic Versions of Pravastatin Sodium Based on Laboratory Data: A retrospective analysis Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) Masanori Suzuki, Masahito Nakazaki et al. 1
16 Facile synthesis and in vitro properties of 1-alkyl- and 1-alkyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline derivatives on PC12 cells European Journal of Medicinal Chemistry Junko Nagai, Kenji Abe et al. 9
17 In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599 Journal of Infection and Chemotherapy Yuji Iizawa, Junko Nagai et al. 68
18 Synthesis and insecticidal activity of novel dihydropyrrole derivatives with N-Sulfanyl, sulfinyl, and sulfonyl moieties Bioorganic & Medicinal Chemistry Shigeru Mio, Ayako Kinoshita et al. 8
19 Synthesis and insecticidal activity of novel N-oxydihydropyrroles: 4-hydroxy-3-mesityl-1-methoxymethoxy derivatives with various substituents at the 5-position Bioorganic & Medicinal Chemistry Shigeru Mio, Ayako Kinoshita et al. 7
20 Statistics of herpes zoter in a city with a population of 200,000. The Nishinihon Journal of Dermatology Yoko Mori, Junko Nagai et al. 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026